Translations:Diabetes medication/17/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 12:09, 4 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Diabetes medication)
Typical reduction in [[glycated hemoglobin]] (A1C) values for metformin is 1.5–2.0%
* [[Metformin]] (Glucophage) may be the best choice for patients who also have heart failure, but it should be temporarily discontinued before any radiographic procedure involving intravenous [[iodine|iodinated]] [[radiocontrast|contrast]], as patients are at an increased risk of [[lactic acidosis]].
* [[Phenformin]] (DBI) was used from 1960s through 1980s, but was withdrawn due to lactic acidosis risk.
* [[Buformin]] also was withdrawn due to lactic acidosis risk.

Typical reduction in glycated hemoglobin (A1C) values for metformin is 1.5–2.0%

  • Metformin (Glucophage) may be the best choice for patients who also have heart failure, but it should be temporarily discontinued before any radiographic procedure involving intravenous iodinated contrast, as patients are at an increased risk of lactic acidosis.
  • Phenformin (DBI) was used from 1960s through 1980s, but was withdrawn due to lactic acidosis risk.
  • Buformin also was withdrawn due to lactic acidosis risk.
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Diabetes_medication/17/en&oldid=110561"